Detalhe da pesquisa
1.
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Nature
; 620(7976): 1063-1070, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587335
2.
Convergent insulin and TGF-ß signalling drives cancer cachexia by promoting aberrant fat body ECM accumulation in a Drosophila tumour model.
EMBO Rep
; 24(12): e57695, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014610
3.
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
BMC Cancer
; 23(1): 459, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208678
4.
Whole-genome characterization of chemoresistant ovarian cancer.
Nature
; 521(7553): 489-94, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26017449
5.
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
BMC Cancer
; 18(1): 87, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357823
6.
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.
Nature
; 527(7578): 398, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503049
7.
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Sci Rep
; 13(1): 21884, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072854
8.
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.
Cell Rep Med
; 4(6): 101055, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220750
9.
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.
Ther Adv Med Oncol
; 15: 17588359231208674, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028140
10.
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Nat Genet
; 55(3): 437-450, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849657
11.
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
medRxiv
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986741
12.
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.
Nat Genet
; 54(12): 1853-1864, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456881
13.
Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer.
Cancer Drug Resist
; 4(3): 573-595, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582310
14.
Tumor-derived MMPs regulate cachexia in a Drosophila cancer model.
Dev Cell
; 56(18): 2664-2680.e6, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473940
15.
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
Nat Commun
; 12(1): 3039, 2021 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031395
16.
Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 13(22)2021 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830797
17.
Abnormal nuclear pore formation triggers apoptosis in the intestinal epithelium of elys-deficient zebrafish.
Gastroenterology
; 136(3): 902-11, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19073184
18.
Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer.
Cancer Res
; 80(22): 4960-4971, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917727
19.
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.
Blood Adv
; 4(20): 5062-5077, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080008
20.
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer.
Nat Commun
; 10(1): 1295, 2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894541